Galectin Therapeutics Ownership & Insider Activity

Galectin Therapeutics Inc

GALTNASDAQ

$3.94

0.308.24%

Last update: Oct 9, 4:00 PM

Galectin Therapeutics Ownership & Insider Activity - Benzinga

Galectin Therapeutics (GALT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 16.2% of shares outstanding. Institutional investors hold 9.8%.

Shares Outstanding

100.850M

Shares Float

76.970M

Insider Shares Owned

16.347M

Insider % Owned

16.2%

Institutional Shares Held

9.930M

Institutional % Held

9.8%

Ownership Breakdown

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Jul 14, 2026	Khurram Jamil	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$4.08	$34K
Jun 26, 2026	Harold Shlevin	—	SELL-OPTIONS	—	$3.13	$114K
Jun 26, 2026	Khurram Jamil	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$3.76	$133K
Jun 23, 2026	Khurram Jamil	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$2.19	$14K
May 26, 2026	Khurram Jamil	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$2.17	$1K